Doximity (DOCS) Stock Price, News & Analysis

Company Overview

Doximity, Inc. operates a digital platform for U.S. medical professionals. Its network enables physicians and other healthcare providers to communicate, collaborate, access medical news and research, maintain professional profiles, and connect with colleagues and patients.

The company offers a range of tools for healthcare organizations and professionals, including telehealth services, digital faxing, scheduling and communication products, and solutions for recruiting and marketing. Doximity also provides pharmaceutical and healthcare companies with digital engagement services designed to reach medical professionals through its platform.

Founded in 2010, Doximity is headquartered in San Francisco and primarily serves the United States healthcare market. The company was co-founded by Jeff Tangney, who serves as chief executive officer, along with Nate Gross and Shari Buck.

Key Stats

• Today's Range: $25.95 to $26.86
• 50-Day Range: $20.42 to $27.35
• 52-Week Range: $17.15 to $76.51
• Volume: 7.21 million shs
• Average Volume: 2.34 million shs
• Market Capitalization: $4.63 billion
• P/E Ratio: 30.58
• Dividend Yield: N/A
• Price Target: $32.18
• Consensus Rating: Hold

Doximity Stock Analysis - MarketRank™

Doximity scored higher than 91% of companies evaluated by MarketBeat, and ranked 34th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Hold

Consensus Rating

Doximity has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 2 strong buy ratings, 7 buy ratings, 14 hold ratings, and 3 sell ratings.

Upside Potential

Doximity has a consensus price target of $32.18, representing about 23.8% upside from its current price of $25.99.

Amount of Analyst Coverage

Doximity has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 28.38%

Earnings Growth

Earnings for Doximity are expected to grow by 28.38% in the coming year, from $0.74 to $0.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Doximity is 30.58, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 42.25.

Price to Earnings Ratio vs. Sector

The P/E ratio of Doximity is 30.58, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 214.59.

Price to Earnings Growth Ratio

Doximity has a PEG Ratio of 20.42. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Doximity has a P/B Ratio of 5.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

11.55% of the float of Doximity has been sold short.

Short Interest Ratio / Days to Cover

Doximity has a short interest ratio ("days to cover") of 4.98.

Change versus previous month

Short interest in Doximity has recently decreased by 23.80%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Doximity does not currently pay a dividend.

Dividend Growth

Doximity does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.36

News Sentiment

Doximity has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 20 news articles for Doximity this week, compared to 7 articles on an average week.

Search Interest

Only 10 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -23% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $441,412.00 in company stock.

Percentage Held by Insiders

31.80% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/19/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NYSE:DOCS
• Previous Symbol: NASDAQ:DOCS
• CIK: 1516513
• Web: doximity.com
• Phone: (650) 549-4330
• Fax: N/A
• Employees: 880
• Year Founded: 2010

Price Target and Rating

• Average Price Target for Doximity: $32.18
• High Price Target: $65.00
• Low Price Target: $18.00
• Potential Upside/Downside: +23.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.31
• Research Coverage: 26 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.85
• Trailing P/E Ratio: 30.58
• Forward P/E Ratio: 35.13
• P/E Growth: 20.42
• Net Income: $196.05 million
• Net Margins: 25.48%
• Pretax Margin: 34.51%
• Return on Equity: 18.06%
• Return on Assets: 15.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.08
• Quick Ratio: 6.08

Sales & Book Value

• Annual Sales: $644.86 million
• Price / Sales: 7.19
• Cash Flow: $1.23 per share
• Price / Cash Flow: 21.06
• Book Value: $5.19 per share
• Price / Book: 5.01

Miscellaneous

• Outstanding Shares: 178,250,000
• Free Float: 121,564,000
• Market Cap: $4.63 billion
• Optionable: N/A
• Beta: 1.25